179 related articles for article (PubMed ID: 32898332)
1. MUC4, MUC16, and TTN genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan-cancer.
Yang Y; Zhang J; Chen Y; Xu R; Zhao Q; Guo W
Clin Transl Med; 2020 Aug; 10(4):e155. PubMed ID: 32898332
[No Abstract] [Full Text] [Related]
2. Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer.
Li X; Pasche B; Zhang W; Chen K
JAMA Oncol; 2018 Dec; 4(12):1691-1698. PubMed ID: 30098163
[TBL] [Abstract][Full Text] [Related]
3. Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas.
Jonckheere N; Van Seuningen I
J Transl Med; 2018 Sep; 16(1):259. PubMed ID: 30236127
[TBL] [Abstract][Full Text] [Related]
4. Expression of membrane-bound mucins in human nasal mucosa: different patterns for MUC4 and MUC16.
Woo HJ; Bae CH; Song SY; Lee HM; Kim YD
Arch Otolaryngol Head Neck Surg; 2010 Jun; 136(6):603-9. PubMed ID: 20566912
[TBL] [Abstract][Full Text] [Related]
5. MUC16 mutation predicts a favorable clinical outcome and correlates decreased Warburg effect in gastric cancer.
Zhao H; Zhang L
Biochem Biophys Res Commun; 2018 Dec; 506(4):780-786. PubMed ID: 30389134
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of MUC16 predicts favourable prognosis in MUC16-mutant cervical cancer related to immune response.
Wang H; Yan C; Ye H
Exp Ther Med; 2020 Aug; 20(2):1725-1733. PubMed ID: 32765681
[TBL] [Abstract][Full Text] [Related]
7. Aggregate analysis based on TCGA: TTN missense mutation correlates with favorable prognosis in lung squamous cell carcinoma.
Cheng X; Yin H; Fu J; Chen C; An J; Guan J; Duan R; Li H; Shen H
J Cancer Res Clin Oncol; 2019 Apr; 145(4):1027-1035. PubMed ID: 30810839
[TBL] [Abstract][Full Text] [Related]
8. DUSP28 links regulation of Mucin 5B and Mucin 16 to migration and survival of AsPC-1 human pancreatic cancer cells.
Lee J; Lee J; Yun JH; Jeong DG; Kim JH
Tumour Biol; 2016 Sep; 37(9):12193-12202. PubMed ID: 27230679
[TBL] [Abstract][Full Text] [Related]
9. MHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: implications on prognostic immunological biomarker and vaccine design.
Cai W; Zhou D; Wu W; Tan WL; Wang J; Zhou C; Lou Y
BMC Genomics; 2018 Aug; 19(1):582. PubMed ID: 30075702
[TBL] [Abstract][Full Text] [Related]
10. Distinct evolution of the human carcinoma-associated transmembrane mucins, MUC1, MUC4 AND MUC16.
Duraisamy S; Ramasamy S; Kharbanda S; Kufe D
Gene; 2006 May; 373():28-34. PubMed ID: 16500040
[TBL] [Abstract][Full Text] [Related]
11. Targeting EGF-receptor(s) - STAT1 axis attenuates tumor growth and metastasis through downregulation of MUC4 mucin in human pancreatic cancer.
Seshacharyulu P; Ponnusamy MP; Rachagani S; Lakshmanan I; Haridas D; Yan Y; Ganti AK; Batra SK
Oncotarget; 2015 Mar; 6(7):5164-81. PubMed ID: 25686822
[TBL] [Abstract][Full Text] [Related]
12. Lung Adenocarcinoma With MUC4 Expression Is Associated With Smoking Status, HER2 Protein Expression, and Poor Prognosis: Clinicopathologic Analysis of 338 Cases.
Rokutan-Kurata M; Yoshizawa A; Sumiyoshi S; Sonobe M; Menju T; Momose M; Koyama M; Shigeto S; Fujimoto M; Zhang M; Morita S; Date H; Haga H
Clin Lung Cancer; 2017 Jul; 18(4):e273-e281. PubMed ID: 28065467
[TBL] [Abstract][Full Text] [Related]
13. Regulation of membrane-associated mucins in the human corneal epithelial cells by dexamethasone.
Seo KY; Chung SH; Lee JH; Park MY; Kim EK
Cornea; 2007 Jul; 26(6):709-14. PubMed ID: 17592322
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional control of the MUC16 promoter facilitates follicle-stimulating hormone peptide-conjugated shRNA nanoparticle-mediated inhibition of ovarian carcinoma in vivo.
Zhang MX; Hong SS; Cai QQ; Zhang M; Chen J; Zhang XY; Xu CJ
Drug Deliv; 2018 Nov; 25(1):797-806. PubMed ID: 29542355
[TBL] [Abstract][Full Text] [Related]
15.
Kanwal M; Ding XJ; Song X; Zhou GB; Cao Y
Oncotarget; 2018 Feb; 9(15):12226-12239. PubMed ID: 29552305
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic cancer counterattack: MUC4 mediates Fas-independent apoptosis of antigen-specific cytotoxic T lymphocyte.
Zhu Y; Zhang JJ; Liang WB; Zhu R; Wang B; Miao Y; Xu ZK
Oncol Rep; 2014 Apr; 31(4):1768-76. PubMed ID: 24534824
[TBL] [Abstract][Full Text] [Related]
17. Catecholamine-Induced β2-adrenergic receptor activation mediates desensitization of gastric cancer cells to trastuzumab by upregulating MUC4 expression.
Shi M; Yang Z; Hu M; Liu D; Hu Y; Qian L; Zhang W; Chen H; Guo L; Yu M; Song L; Ma Y; Guo N
J Immunol; 2013 Jun; 190(11):5600-8. PubMed ID: 23630346
[TBL] [Abstract][Full Text] [Related]
18. Peritoneal dissemination of ovarian cancer: role of MUC16-mesothelin interaction and implications for treatment.
Coelho R; Marcos-Silva L; Ricardo S; Ponte F; Costa A; Lopes JM; David L
Expert Rev Anticancer Ther; 2018 Feb; 18(2):177-186. PubMed ID: 29241375
[TBL] [Abstract][Full Text] [Related]
19. Titin mutation associated with responsiveness to checkpoint blockades in solid tumors.
Jia Q; Wang J; He N; He J; Zhu B
JCI Insight; 2019 May; 4(10):. PubMed ID: 31092729
[TBL] [Abstract][Full Text] [Related]
20. IL-6 induces MUC4 expression through gp130/STAT3 pathway in gastric cancer cell lines.
Mejías-Luque R; Peiró S; Vincent A; Van Seuningen I; de Bolós C
Biochim Biophys Acta; 2008 Oct; 1783(10):1728-36. PubMed ID: 18573283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]